In addition, Eph has been reported to suppress the wild type of EGFR pathway [44], whereas in patients with EGFR-mutation, the EGFR-independent tumor growth-promoting effects may outweigh the inhibitory effects of EphB4. Here, EPHB4 is linked to neoplasm.